These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38118005)
1. Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience. Poudyal N; Holm M; Joh HS; Gautam S; Sujan MJ; Kwon SY; Sahikh A; Shaw A; Gallagher P; Prifti K; Cho A; Chi KK; Aboushady AT; MacWright WR; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S519-S527. PubMed ID: 38118005 [TBL] [Abstract][Full Text] [Related]
2. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA). Holm M; MacWright WR; Poudyal N; Shaw AG; Joh HS; Gallagher PF; Kim JH; Shaikh AT; Seo HJ; Kwon SY; Prifti K; Dolabella B; Taylor BEW; Yeats C; Aanensen DM; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S500-S506. PubMed ID: 38118015 [TBL] [Abstract][Full Text] [Related]
3. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual). Joh HS; Dolabella B; Early E; Stelling J; Ak G; Upadhyaya MK; Rahman A; Chuki P; MacWright WR; Ondoa P; Sarkar S; Moore C; Holm M; Leslie T; Zellweger RM; Paing G; Kwon SY; Marks F; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S536-S542. PubMed ID: 38118006 [TBL] [Abstract][Full Text] [Related]
4. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening. Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007 [TBL] [Abstract][Full Text] [Related]
5. The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience. Leslie T; Parry C; Ondoa P; Walsh T; Moore C; Poudyal N; Marks F; Gordon NC Clin Infect Dis; 2023 Dec; 77(Suppl 7):S497-S499. PubMed ID: 38118008 [TBL] [Abstract][Full Text] [Related]
6. Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience. Maharjan S; Gallagher P; Gautam M; Joh HS; Sujan MJ; Aboushady AT; Kwon SY; Gautam S; Upadhyaya MK; Jha R; Acharya J; MacWright WR; Marks F; Stelling J; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S560-S568. PubMed ID: 38118014 [TBL] [Abstract][Full Text] [Related]
7. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project. Aboushady AT; Sujan MJ; Pham K; Clark A; Marks F; Holm M; Joh HS; Poudyal N; Stelling J Clin Infect Dis; 2023 Dec; 77(Suppl 7):S581-S587. PubMed ID: 38118016 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward. Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018 [TBL] [Abstract][Full Text] [Related]
10. Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic. Kwon SY; Gautam S; Poudel K; Banneheke H; Ferreira D; Gautam M; Hau'ofa M; Mahmood N; Phommalad B; Sujan MJ; Yangzom P; Joh HS; Shaw A; Dolabella B; Seo HJ; Kim JH; Gallagher P; MacWright WR; Poudyal N; Marks F; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S543-S548. PubMed ID: 38118010 [TBL] [Abstract][Full Text] [Related]
11. Laboratory-based surveillance of antimicrobial resistance in regions of Kenya: An assessment of capacities, practices, and barriers by means of multi-facility survey. Moirongo RM; Aglanu LM; Lamshöft M; Adero BO; Yator S; Anyona S; May J; Lorenz E; Eibach D Front Public Health; 2022; 10():1003178. PubMed ID: 36518572 [TBL] [Abstract][Full Text] [Related]
12. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. European Antimicrobial Resistance Collaborators Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350 [TBL] [Abstract][Full Text] [Related]
13. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data. Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase. Thomsen J; Abdulrazzaq NM; AlRand H; Front Public Health; 2023; 11():1247627. PubMed ID: 38074700 [TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis. Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E; BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis. Mouiche MMM; Moffo F; Akoachere JTK; Okah-Nnane NH; Mapiefou NP; Ndze VN; Wade A; Djuikwo-Teukeng FF; Toghoua DGT; Zambou HR; Feussom JMK; LeBreton M; Awah-Ndukum J BMC Public Health; 2019 Aug; 19(1):1135. PubMed ID: 31426792 [TBL] [Abstract][Full Text] [Related]
17. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149 [TBL] [Abstract][Full Text] [Related]
18. Strengthening antimicrobial resistance surveillance systems: a scoping review. Do PC; Assefa YA; Batikawai SM; Reid SA BMC Infect Dis; 2023 Sep; 23(1):593. PubMed ID: 37697310 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015. Roberts T; Dahal P; Shrestha P; Schilling W; Shrestha R; Ngu R; Huong VTL; van Doorn HR; Phimolsarnnousith V; Miliya T; Crump JA; Bell D; Newton PN; Dittrich S; Hopkins H; Stepniewska K; Guerin PJ; Ashley EA; Turner P Int J Infect Dis; 2022 Sep; 122():612-621. PubMed ID: 35817284 [TBL] [Abstract][Full Text] [Related]
20. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area. Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M; BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]